Why I Stopped Taking NMN? A Scientific Look at Safety, Risks, and Emerging Evidence

Why have both researchers and biohackers, including myself, decided to stop taking NMN (nicotinamide mononucleotide)? Once celebrated as a cutting-edge anti-aging molecule, NMN has come under intense scrutiny due to evolving ​clinical data, potential side effects, and FDA restrictions​.

This article critically examines the reasons behind this shift—integrating ​peer-reviewed research​, user-reported outcomes, and regulatory developments—to help health professionals, supplement users, and biomedical researchers make informed decisions.

What Is NMN and Why Was It Considered Promising?

NMN was promoted due to its role as a precursor to NAD⁺, a vital coenzyme in metabolism and DNA repair.

Nicotinamide mononucleotide (NMN) has gained significant attention in recent years as a crucial precursor to nicotinamide adenine dinucleotide (NAD+), a vital cofactor involved in numerous biological processes, particularly in aging and metabolism. As the global population ages, there is an increasing focus on NMN's potential therapeutic applications for age-related conditions and metabolic disorders. This literature review explores key findings regarding NMN's role in various biological systems, its therapeutic potentials, and the underlying mechanisms by which it exerts its effects.

• NAD⁺ levels can ​decline by ~50% by middle age​, impairing mitochondrial efficiency and cellular resilience.
• Animal studies demonstrated metabolic and neuroprotective benefits, which fueled public interest—but [human evidence remains limited.

Why Is NMN No Longer Considered Safe?

Is NMN safe for individuals at risk of cancer?

The answer is: No. Some studies show NMN may inadvertently support tumor cell survival.

• A 2021 Nature Communications study revealed that high NAD⁺ levels enhanced DNA repair in precancerous cells, allowing them to evade apoptosis.
• Overexpression of NAMPT—a key enzyme in NAD⁺ synthesis—is linked to poorer outcomes in glioblastoma, colorectal, and pancreatic cancers.

What side effects have users reported?

Observational data and reviews note minor but notable adverse reactions.

• In a Frontiers trial of 66 subjects (150 mg/day NMN for 60 days), NAD⁺ levels rose by ​38% by day 60​, with no serious adverse events reported; side effects were minimal.
• However, narrative reviews and meta-analyses list minor effects like GI upset, fatigue, flushing, and headache in some users.

How did the FDA’s stance impact NMN availability?

The FDA ruled NMN is excluded from the dietary supplement category effective October 11, 2022.

• FDA letters confirmed β‑NMN is excluded under FDC Act § 201(ff)(3)(B)(ii) due to its IND status, barring supplement marketing.
• Legal and trade organizations (e.g. FDA Law Blog, Nutraceuticals World) documented this policy and related enforcement delays and litigation.
• By early 2024, enforcement was paused—but classification remains, making NMN sales as supplements legally questionable.

Does NMN Provide Proven Human Benefits?

Are clinical trials supportive of NMN’s efficacy?

Evidence is restricted to small-scale short-term studies.

• A randomized controlled trial with 25 overweight pre‑diabetic women found that [250 mg/day NMN for 10 weeks significantly increased NAD⁺ in PBMCs and improved insulin sensitivity, but did not alter skeletal muscle NAD⁺ levels.
• Another study on 66 healthy adults supplementing 150 mg/day for 60 days showed a ​38% increase in NAD⁺ levels​, but no changes in lipids or blood pressure and only mild symptoms in both active and placebo groups.

How long does NMN stay active in the system?

Its effects appear transient; NAD⁺ peaks after ingestion but tapers within 12 hours.

• Pharmacokinetic studies suggest that maintaining elevated NAD⁺ may require ​daily or bi-daily dosing​, raising questions about long-term exposure, though direct NMN blood-level kinetics are yet unstandardized.

Should Cancer Patients Avoid NMN?

Likely yes—due to possible support of tumor metabolism.

• Elevated NAD⁺ synthesis via NMN may feed tumor growth—particularly where NAMPT is upregulated, as seen in aggressive cancers.
• While some pathways show anti-tumor potential in specific contexts, recommending NMN for high-risk or oncology patients remains premature and medically unadvised.

What Are the Long-Term Risks of Daily NMN Use?

Risks include biological, economic, and regulatory concerns.

• ​Oncogenic risks​: NAD⁺ may support precancerous or malignant survival.
• ​Adverse reactions​: Minor symptoms reported in up to ~20% of users.
• ​Regulatory ambiguity​: FDA exclusion, disposal of NDI petitions, and pending litigation create market instability.
• ​Product inconsistency​: Studies found up to 28% discrepancy between labeled and actual NMN content in supplements.
• ​Cost​: Monthly expenses often exceed ​USD 50–150​, without demonstrated long‑term benefit.

Is NMN Still Worth Taking?

Not generally—except under controlled research circumstances.

• Though NMN can raise NAD⁺ levels acutely, ​long-term safety, impact on longevity, and disease prevention remain unproven​, especially in healthy individuals.
• For ​biomedical researchers​, NMN illustrates the translational gap between promising preclinical mechanisms and human health outcomes.
• For those with ​chronic illnesses or cancer risk​, NMN should be used only within supervised clinical protocols.

FAQ

What are the dangers of NMN?

Nicotinamide Mononucleotide (NMN) is generally considered safe for most individuals when taken at recommended dosages. However, some users may experience mild side effects such as nausea, stomach discomfort, diarrhea, headaches, fatigue, or insomnia. These symptoms are typically transient and resolve upon discontinuation of the supplement. It's important to consult with a healthcare provider before starting NMN supplementation, especially for those with underlying health conditions or who are pregnant or breastfeeding.

Does NMN stop grey hair?

There is currently no conclusive scientific evidence to support the claim that NMN can reverse or prevent grey hair. While NMN has shown potential in promoting hair growth in animal studies, its effect on hair pigmentation remains unproven in humans. Anecdotal reports suggest some individuals have noticed improvements, but these are not substantiated by rigorous clinical research.

What is the controversy with NMN?

The primary controversy surrounding NMN revolves around its regulatory status and the robustness of supporting scientific evidence. In 2022, the U.S. Food and Drug Administration (FDA) excluded NMN from the definition of a dietary supplement, citing its investigation as a drug. This decision led to legal challenges from industry groups. While enforcement of this ruling was paused in 2024, the debate continues regarding NMN's classification and the need for further clinical trials to confirm its efficacy and safety.

Is NMN toxic to the liver?

Research indicates that NMN supplementation does not pose significant liver toxicity risks. A subacute toxicity study in mice demonstrated that oral administration of NMN substantially elevated NAD+ levels in tissues without causing liver damage. Additionally, a study on β-NMN reported no significant side effects on liver function. These findings suggest that NMN is well-tolerated by the liver, but more human studies are needed to confirm these results.

Why is NMN so expensive?

The high cost of NMN supplements can be attributed to several factors. The production of NMN involves complex and costly manufacturing processes to ensure high purity and quality. Additionally, the research and development required to substantiate its health benefits contribute to the overall expense. Market demand and limited supply also play roles in driving up prices. As the supplement gains popularity, these factors collectively contribute to its premium pricing.

Advanced Literature Review with PubMed.ai

Still have questions about NMN’s safety, molecular effects, or clinical trial results? Leverage ​PubMed.ai​—an AI-enhanced research platform for biomedical investigators and healthcare professionals.

• Generate structured literature summaries
• Refine complex queries with natural language assistance
• Extract clinical and mechanistic insights from peer-reviewed publications
• Stay updated on oncology, longevity, metabolism, and aging-related research

PubMed.ai empowers rigorous, evidence-based decision-making—especially when evaluating supplements like NMN with evolving scientific and regulatory profiles. Start your research here.